Arris Holdings Inc.

Arris Holdings Inc.

January 15, 2014 16:19 ET

Arris Holdings, Inc. and Global Hemp Group Attract High Caliber Advisors

SURREY, BRITISH COLUMBIA--(Marketwired - Jan. 15, 2014) - Arris Holdings Inc. ("Arris" or the "Company") (CNSX:AAF) (FRANKFURT:ANI) and its subsidiary Global Hemp Group, Inc. are pleased to announce the formation of its International Advisory Board ("IAB").

As The Company begins to establish its global base of operations, this influential group of international business leaders will provide unique perspective to the Board of Directors and CEO. Each of these individuals brings a wealth of knowledge in their areas of expertise and will contribute significantly to the overall advancement of the hemp industry and the success of our company. Members of the IAB will introduce hemp to their influential global network of business leaders, and potential new markets that span across many industries.

Mr. Clement Aboge, Africa Frontier Partners, advises on matters concerning the development of hemp as an agricultural crop in Africa to improve the quality of life of millions of people in the most impoverished regions.

Dr. Bruce F. Mackler has extensive experience working with the U.S. Food & Drug Administration and vast knowledge of scientific and regulatory requirements. Dr. Mackler will advise on FDA due diligence and implementing FDA strategies. In addition, as an attorney, Dr. Mackler has done extensive legal work with the FDA and DEA.

Dr. Paul T. Perrault will advise the Company on agricultural research and rural development. His experience working with World institutions all across Africa will contribute significantly to The Company's social venture projects.

Ms. Jan Strode, Chairman and CEO of CEO ADVISORS, Inc. is a nationally recognized expert in the strategic use of communications. Ms. Strode manages image strategies for Fortune 500 companies and high profile individuals.

Dato Dr. Kim Tan, SpringHill Management Ltd. brings global knowledge and expertise in the area of social venture capital investments. Dr. Tan's experience in biotech and working with both NGO's and government agencies will be invaluable to The Company.

Charles Larsen says "The appointment of these influential business leaders to our International Advisory Board is the culmination of years of planning and preparation that has lead to the development of these key relationships. These advisors add a broad base of experience and knowledge that is complimentary and synergistic, and adds strength and depth to our international Advisory Board. The Company, its shareholders and our customers will benefit greatly from their advice".

On behalf of the board

Charles Larsen, CEO

Forward Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Arris Holdings Inc.
    1-604-592-6881 or 1-877-469-HEMP (4367)